PE-22-28 is a synthetic heptapeptide derived from spadin that selectively inhibits TREK-1 potassium channels. In rodent models, it accelerates hippocampal
Read more PE-22-28 and Neuroplasticity: Preclinical Evidence, Mechanisms, and Limitations
PE-22-28 is a synthetic heptapeptide derived from spadin that selectively inhibits TREK-1 potassium channels. In rodent models, it accelerates hippocampal
Read more PE-22-28 and Neuroplasticity: Preclinical Evidence, Mechanisms, and Limitations
Semax is a synthetic ACTH(4-10) analog that exhibits potent neuroprotective, neurotrophic, and cognitive-modulating properties across clinical and pre-clin
Read more Semax Research Guide: Mechanisms, Neurotrophic Actions, and Clinical Evidence